azetirelin has been researched along with flupenthixol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, M; Koshikawa, N; Ozawa, Y; Sasamata, M; Yamamoto, M | 1 |
| Cools, AR; Kobayashi, M; Koshida, Y; Koshikawa, N; Miwa, Y; Miyata, N | 1 |
2 other study(ies) available for azetirelin and flupenthixol
| Article | Year |
|---|---|
Central dopaminergic actions of YM-14673, a new TRH analogue, in rodents.
Topics: alpha-Methyltyrosine; Animals; Apomorphine; Azetidines; Azetines; Behavior, Animal; Dipeptides; Dopamine Agents; Flupenthixol; Haloperidol; Male; Methamphetamine; Methyltyrosines; Mice; Mice, Inbred ICR; Motor Activity; Rats; Rats, Inbred Strains; Stereotyped Behavior; Thyrotropin-Releasing Hormone | 1990 |
YM-14673, a thyrotropin-releasing hormone analogue, injected into the nucleus accumbens and the striatum produces repetitive jaw movements in rats.
Topics: Animals; Azetidines; Behavior, Animal; Corpus Striatum; Dipeptides; Dose-Response Relationship, Drug; Electromyography; Flupenthixol; Injections, Spinal; Jaw; Male; Nucleus Accumbens; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Serotonin Antagonists; Thyrotropin-Releasing Hormone | 1995 |